Eqv Ventures [EQV] vs Inflection Point [IPXX] Detailed Stock Comparison
Eqv Ventures
Inflection Point
TLDR: Quick Comparison Summary
We found some data (4 metrics), but not enough for a complete comparison. Metrics like P/E ratio, profitability, and financial health are still available in the detailed tabs below.
View Metrics Details
Vital Metrics Comparison
Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.
| Metric | Eqv Ventures | Inflection Point | Better |
|---|---|---|---|
| Price-to-Book Ratio | 1.32 | 0.64 | Inflection Point |
| Debt-to-Equity Ratio | 0.00 | 0.00 | Tie |
| Profit Margin (TTM) | 0.00% | N/A | N/A |
| Operating Margin (TTM) | 0.00% | N/A | N/A |
| 1-Year Return | 4.95% | 70.69% | Inflection Point |
| Enterprise Value | $462.18M | $0 | Eqv Ventures |
Eqv Ventures vs Inflection Point Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Eqv Ventures | 0.00% | 0.00% | 0.10% | -1.33% | 2.97% | 4.21% |
| Inflection Point | 41.09% | 49.80% | 88.66% | 161.43% | 299.38% | 109.86% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Eqv Ventures | 4.95% | 4.74% | 4.74% | 4.74% | 4.74% | 4.74% |
| Inflection Point | 70.69% | 81.64% | 81.64% | 81.64% | 81.64% | 81.64% |
News Based Sentiment: Eqv Ventures vs Inflection Point
Eqv Ventures
News based Sentiment: MIXED
September saw positive developments for EQV Ventures with the continued progress towards the Presidio merger and increased institutional investment. However, cautious forecasts, a lack of analyst coverage, and limited insider activity data create a mixed picture for investors, suggesting a need for careful monitoring and a balanced approach.
Inflection Point
News based Sentiment: NEUTRAL
The month's narrative centers around increased visibility for IPXX as a small-cap stock, but the reports also highlight the inherent risks of this market segment. While positive in terms of attention, the overall impact on the investment case is neutral, requiring further investigation.
Performance & Financial Health Analysis: Eqv Ventures vs Inflection Point
| Metric | EQV | IPXX |
|---|---|---|
| Market Information | ||
| Market Cap | $463.55M | $811.25M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 68,600 | 11,317,539 |
| 90 Day Avg. Volume | 42,587 | 6,956,464 |
| Last Close | $10.39 | $25.96 |
| 52 Week Range | $9.88 - $10.74 | $5.56 - $28.23 |
| % from 52W High | -3.27% | -8.04% |
| All-Time High | $10.74 (Jun 16, 2025) | $28.23 (Oct 03, 2025) |
| % from All-Time High | -3.26% | -8.04% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | N/A |
| Operating Margin (TTM) | 0.00% | N/A |
| Return on Equity (TTM) | N/A | N/A |
| Debt to Equity (MRQ) | 0.00 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.30 | $40.57 |
| Cash per Share (MRQ) | $0.02 | $0.02 |
| Operating Cash Flow (TTM) | $-1,057,380 | $0 |
| Levered Free Cash Flow (TTM) | $0 | $0 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Eqv Ventures vs Inflection Point
| Metric | EQV | IPXX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | N/A | N/A |
| Price to Book (MRQ) | 1.32 | 0.64 |
| Market Capitalization | ||
| Market Capitalization | $463.55M | $811.25M |
| Enterprise Value | $462.18M | $0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | N/A |
| Enterprise to EBITDA | N/A | N/A |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | $-0.30 | $40.57 |
Financial Statements Comparison: Eqv Ventures vs Inflection Point
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EQV | IPXX |
|---|---|---|
| Revenue/Sales | $0 | $0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-332,208 | $-1.92M |
| EBITDA | $-332,208 | $-5.35M |
| Pre-Tax Income | $2.96M | $1.51M |
| Income Tax | N/A | N/A |
| Net Income (Profit) | $2.96M | $1.51M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EQV | IPXX |
|---|---|---|
| Cash & Equivalents | $1.07M | $141,201 |
| Total Current Assets | $1.20M | $222,948 |
| Total Current Liabilities | $1.01M | $2.73M |
| Long-Term Debt | N/A | N/A |
| Total Shareholders Equity | $347.07M | $253.54M |
| Retained Earnings | $-12.63M | $-15.60M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EQV | IPXX |
|---|---|---|
| Operating Cash Flow | $-332,208 | $1.51M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-363,595 | $-490,386 |
| Debt Repayment | N/A | $0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EQV | IPXX |
|---|---|---|
| Shares Short | 987 | N/A |
| Short Ratio | 0.03 | N/A |
| Short % of Float | 0.00% | N/A |
| Average Daily Volume (10 Day) | 68,600 | 11,317,539 |
| Average Daily Volume (90 Day) | 42,587 | 6,956,464 |
| Shares Outstanding | 44.57M | 31.25M |
| Float Shares | 23.53M | N/A |
| % Held by Insiders | 0.02% | N/A |
| % Held by Institutions | 0.84% | N/A |
Dividend Analysis & Yield Comparison: Eqv Ventures vs Inflection Point
| Metric | EQV | IPXX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |